What is GlaxoSmithKline Consumer Nigeria Revenue per Share?
GlaxoSmithKline Consumer Nigeria's revenue per share for the
three
months ended in Jun. 2023 was ₦3.03.
GlaxoSmithKline Consumer Nigeria's revenue per share for the trailing twelve months (TTM) ended in Jun. 2023 was ₦11.78.
Warning Sign:
GlaxoSmithKline Consumer Nigeria PLC revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of GlaxoSmithKline Consumer Nigeria was -17.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 6.90% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 8.60% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was -1.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for GlaxoSmithKline Consumer Nigeria's Revenue per Share or its related term are showing as below:
NSA:GLAXOSMITH'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -21 Med: 6.8 Max: 13
Current: 6.9
During the past 13 years, GlaxoSmithKline Consumer Nigeria's highest 3-Year average Revenue Per Share Growth Rate was 13.00% per year. The lowest was -21.00% per year. And the median was 6.80% per year.
NSA:GLAXOSMITH's 3-Year Revenue Growth Rate is not ranked
in the Drug Manufacturers industry.
Industry Median: 6.4
vs NSA:GLAXOSMITH: 6.90
GlaxoSmithKline Consumer Nigeria Revenue per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
GlaxoSmithKline Consumer Nigeria Revenue per Share Chart
Competitive Comparison of GlaxoSmithKline Consumer Nigeria's Revenue per Share
For the Drug Manufacturers - General subindustry, GlaxoSmithKline Consumer Nigeria's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
GlaxoSmithKline Consumer Nigeria's PS Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, GlaxoSmithKline Consumer Nigeria's PS Ratio distribution charts can be found below:
* The bar in red indicates where GlaxoSmithKline Consumer Nigeria's PS Ratio falls into.
GlaxoSmithKline Consumer Nigeria Revenue per Share Calculation
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₦11.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Revenue per Share Explanation
In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.
Peter Lynch categorized companies according to their revenue growth:
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
GlaxoSmithKline Consumer Nigeria Revenue per Share Related Terms
Thank you for viewing the detailed overview of GlaxoSmithKline Consumer Nigeria's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
GlaxoSmithKline Consumer Nigeria (NSA:GLAXOSMITH) Business Description
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, the Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines, and nutritional healthcare; and the Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, and others. The generates maximum revenue from the Pharmaceuticals segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NSA:GLAXOSMITH has been successfully added to your 